慢性乙型肝炎患者肝脏损伤相关的炎症细胞因子谱比急性乙肝更广更强
该研究检测了急性乙肝、HBeAg血清学转换的慢性乙肝及停用核苷类似物治疗的慢性乙肝患者共25种炎症标志物。结果显示各阶段乙肝均以髓系标志物为主,但慢性患者可检测到更多炎症标志物,包括Fas配体、TRAIL和TNF-α等细胞毒性效应分子浓度升高。
要点
- 各阶段乙肝炎症谱均以髓系标志物为主。
- 慢性乙肝患者可检测到更多炎症标志物。
- 慢性患者Fas配体、TRAIL和TNF-α浓度升高。
核心结论
- 慢性乙肝患者的炎症细胞因子谱比急性乙肝更广更强,尤其在细胞毒性效应分子方面。
研究设计与样本
- 研究检测了急性乙肝、HBeAg血清学转换的慢性乙肝及停用核苷类似物治疗的慢性乙肝患者共25种炎症标志物。
主要发现
- 所有乙肝阶段的炎症谱均以髓系标志物为主。
- 慢性乙肝患者可检测到更多炎症标志物。
- 慢性患者中细胞毒性效应分子Fas配体、TRAIL和TNF-α浓度升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Liver damage in hepatitis B is immune driven and correlates with inflammatory markers in patient serum. There is no comparison of these markers to determine if inflammatory profiles are distinct to different types of liver damage across patients at different stages of disease. We measured 25 inflammatory markers in patients with acute hepatitis B and chronic hepatitis B with hepatitis B e antigen seroconversion and chronic patients stopping nucleoside analogue therapy. Myeloid markers dominated the inflammatory profile in all stages of hepatitis B. More inflammatory markers were detectable in chronic patients, including elevated concentrations of cytotoxic effectors Fas ligand, TRAIL, and TNF-α.
引用
- Johnson Valiente A, Liem KS, Schwarz KB, et al. The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis B. J Infect Dis. 2022. PMID: 34286845. doi:10.1093/infdis/jiab373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。